A detailed history of Kovitz Investment Group Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 6,497 shares of INCY stock, worth $558,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,497
Previous 20,617 68.49%
Holding current value
$558,482
Previous $1.25 Million 64.58%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$55.17 - $71.22 $779,000 - $1.01 Million
-14,120 Reduced 68.49%
6,497 $442,000
Q1 2025

May 13, 2025

BUY
$60.0 - $75.26 $972,180 - $1.22 Million
16,203 Added 367.08%
20,617 $1.25 Million
Q4 2024

Aug 25, 2025

SELL
$65.08 - $83.38 $135,561 - $173,680
-2,083 Reduced 32.06%
4,414 $304,000
Q4 2024

Feb 14, 2025

BUY
$65.08 - $83.38 $287,263 - $368,039
4,414 New
4,414 $304,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $19.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Kovitz Investment Group Partners, LLC Portfolio

Follow Kovitz Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.